Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 10980

1.

Cognitive dysfunction and hepatitis C virus infection.

Solinas A, Piras MR, Deplano A.

World J Hepatol. 2015 May 8;7(7):922-5. doi: 10.4254/wjh.v7.i7.922.

2.

New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.

Patel R, DuPont HL.

Clin Infect Dis. 2015 May 15;60 Suppl 2:S108-21. doi: 10.1093/cid/civ177.

PMID:
25922396
3.

Acute liver failure in dogs and cats.

Weingarten MA, Sande AA.

J Vet Emerg Crit Care (San Antonio). 2015 Apr 16. doi: 10.1111/vec.12304. [Epub ahead of print]

PMID:
25882813
4.

Activation of NMDA receptor by elevated homocysteine in chronic liver disease contributes to encephalopathy.

Choudhury S, Borah A.

Med Hypotheses. 2015 Apr 3. pii: S0306-9877(15)00142-5. doi: 10.1016/j.mehy.2015.03.027. [Epub ahead of print]

PMID:
25881985
5.

Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.

Qvartskhava N, Lang PA, Görg B, Pozdeev VI, Ortiz MP, Lang KS, Bidmon HJ, Lang E, Leibrock CB, Herebian D, Bode JG, Lang F, Häussinger D.

Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5521-6. doi: 10.1073/pnas.1423968112. Epub 2015 Apr 13.

PMID:
25870278
6.

Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure events.

Lo Re V 3rd, Carbonari DM, Forde KA, Goldberg D, Lewis JD, Haynes K, Leidl KB, Reddy RK, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA.

Pharmacoepidemiol Drug Saf. 2015 Apr 10. doi: 10.1002/pds.3774. [Epub ahead of print]

PMID:
25866286
7.

Expression of glutamine transporter isoforms in cerebral cortex of rats with chronic hepatic encephalopathy.

Leke R, Escobar TD, Rama Rao KV, Silveira TR, Norenberg MD, Schousboe A.

Neurochem Int. 2015 Apr 1. pii: S0197-0186(15)00048-0. doi: 10.1016/j.neuint.2015.03.005. [Epub ahead of print]

PMID:
25842041
8.

Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt.

Richter J, Bode JG, Blondin D, Kircheis G, Kubitz R, Holtfreter MC, Müller-Stöver I, Breuer M, Hüttig F, Antoch G, Häussinger D.

Lancet Infect Dis. 2015 Mar 10. pii: S1473-3099(15)70009-5. doi: 10.1016/S1473-3099(15)70009-5. [Epub ahead of print] Review.

PMID:
25769268
9.

Nutrition in the management of cirrhosis and its neurological complications.

Bémeur C, Butterworth RF.

J Clin Exp Hepatol. 2014 Jun;4(2):141-50. doi: 10.1016/j.jceh.2013.05.008. Epub 2013 Jun 11. Review.

10.

[Hepatic encephalopathy causes permanent damage].

Füessl HS.

MMW Fortschr Med. 2015 Jan 19;157(1):27. German. No abstract available.

PMID:
25743291
11.

Population-Representative Incidence of Drug-Induced Acute Liver Failure Based on an Analysis of an Integrated Health Care System.

Goldberg DS, Forde KA, Carbonari DM, Lewis JD, Leidl KB, Reddy KR, Haynes K, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA, Lo Re V 3rd.

Gastroenterology. 2015 Feb 28. pii: S0016-5085(15)00299-1. doi: 10.1053/j.gastro.2015.02.050. [Epub ahead of print]

PMID:
25733099
12.

Telaprevir- and Boceprevir-Based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.

Verna EC, Saxena V, Burton JR Jr, O'Leary JG, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS Jr, Terrault NA; for the CRUSH-C Consortium.

Transplantation. 2015 Feb 24. [Epub ahead of print]

PMID:
25715116
13.

Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.

Chen Y, Guo J, Qian G, Fang D, Shi D, Guo L, Li L.

J Gastroenterol Hepatol. 2015 Feb 25. doi: 10.1111/jgh.12932. [Epub ahead of print]

PMID:
25711972
14.

Decreased Tim-3 expression is associated with functional abnormalities of monocytes in decompensated cirrhosis without overt bacterial infection.

Shi Y, Wu W, Yang Y, Yang Q, Song G, Wu Y, Wei L, Chen Z.

J Hepatol. 2015 Feb 18. pii: S0168-8278(15)00127-0. doi: 10.1016/j.jhep.2015.02.020. [Epub ahead of print]

PMID:
25701694
15.

Gut microbiota and liver diseases.

Minemura M, Shimizu Y.

World J Gastroenterol. 2015 Feb 14;21(6):1691-702. doi: 10.3748/wjg.v21.i6.1691.

16.

Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.

Zhu GQ, Shi KQ, Huang S, Wang LR, Lin YQ, Huang GQ, Chen YP, Braddock M, Zheng MH.

Aliment Pharmacol Ther. 2015 Apr;41(7):624-35. doi: 10.1111/apt.13122. Epub 2015 Feb 13.

PMID:
25684317
17.

Reply: To PMID 24365582.

Kircheis G, Hilger N, Häussinger D.

Gastroenterology. 2015 Mar;148(3):665-6. doi: 10.1053/j.gastro.2015.01.035. Epub 2015 Feb 3. No abstract available.

PMID:
25659764
18.

Bariatric surgery in patients with cirrhosis with and without portal hypertension: a single-center experience.

Pestana L, Swain J, Dierkhising R, Kendrick ML, Kamath PS, Watt KD.

Mayo Clin Proc. 2015 Feb;90(2):209-15. doi: 10.1016/j.mayocp.2014.11.012.

PMID:
25659239
19.

Evaluation of rifaximin in management of hepatic encephalopathy.

Wahib AA, El-Deen Salem MN, Ahmed MA, El-Dessouky YM, El-Tiby DM, El-Mola K, El-Sayed AM.

J Egypt Soc Parasitol. 2014 Dec;44(3):677-85.

PMID:
25643509
20.

Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.

Krashin E, Lishner M, Chowers M, Reisfeld S.

Isr Med Assoc J. 2014 Dec;16(12):801-2. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk